ArticleScientific reports2025
Determination of the prevalence of hypervirulent Klebsiella pneumoniae strains in Northeast Iran, Mashhad.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Mortality risk of carbapenem-resistant hypervirulentFrontiers in public health · 2025Pooled it
- Genomic Epidemiology of Multidrug-Resistant Clinical Klebsiella pneumoniae From Pakistan.MicrobiologyOpen · 2026Article
- Emerging hypervirulent and extensively drug-resistant Klebsiella pneumoniae with potent biofilm formation as a new clinical challenge.Molecular biology reports · 2026Article
- Emergence and genomic characterization of hypervirulent ST23/K1Frontiers in microbiology · 2026Article
- The promising activity of apple cider vinegar on MDR Klebsiella spp. (K. variicola and K. pneumoniae) emerging pathogens in chicken.Veterinary research communications · 2025Article
- Burden of antimicrobial resistance and estimated economic impact ofNew microbes and new infections · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypervirulent Klebsiella pneumoniae (hvKp) has emerged as a clinically significant pathogen that can cause severe infections, even in immunocompetent hosts. Unlike classical K. pneumoniae (cKp), hvKp exhibits enhanced virulence characterized by hypermucoviscosity and the presence of key genetic determinants. Its increasing detection in hospital settings, particularly in intensive care units (ICUs), raises concerns regarding nosocomial transmission and antibiotic resistance. A total of 187 K. pneumoniae isolates from patients at the Imam Reza Hospital, Mashhad, Iran, were screened phenotypically and genotypically. The hypermucoviscous phenotype was assessed using the string test and PCR was used to detect virulence genes (rmpA, rmpA2, and iucA). Antimicrobial susceptibility testing and extended-spectrum β-lactamase (ESBL) detection were conducted, and statistical analyses were performed to compare the hvKp and cKp isolates. hvKp accounted for 9.63% of all isolates. These strains were significantly associated with the presence of rmpA, rmpA2, and iucA genes. Although no statistically significant differences in antimicrobial resistance were observed between hvKp and cKp, the hvKp strains exhibited relatively lower resistance rates. A slightly higher but non-significant ESBL production rate was noted among the hvKp isolates. Diabetes and renal failure emerged as significant risk factors for hvKp infection, whereas age showed no such association. The detection of hvKp in ICU settings, coupled with its virulence potential and relative antibiotic susceptibility, underscores the urgent need for enhanced surveillance, infection control, and targeted antimicrobial stewardship. Future research should focus on the genomic evolution of hvKp and its interplay with host factors to develop effective prevention and treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.